School of Medicine
Showing 1-5 of 5 Results
Quynh-Thu Le, MD
Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor, by courtesy, of Otolaryngology-Head and Neck Surgery
Current Research and Scholarly Interests My laboratory research interest focuses on the identification of biomarkers for prognosis in patients with head & neck or lung cancers. I am also conducting a number of clinical trials specifically in patients with head & neck cancers.
Billy W. Loo, Jr., MD, PhD, DABR
Professor of Radiation Oncology (Radiation Therapy) at the Stanford University Medical Center
Current Research and Scholarly Interests My clinical specialty is radiation treatment of thoracic cancers.
My research is on developing next-generation ultra-rapid radiation therapy technology (PHASER) and studying the radiobiological effects of FLASH treatment.
My clinical research is on advanced 4-D image-guided radiation therapy and stereotactic ablative radiotherapy (SABR), and functional and metabolic imaging and imaging biomarkers.
Postdoc Res Affiliate, Radiation Oncology - Radiation Physics
Bio Arian Lundberg, Ph.D. MSc. is a Post-Doctoral scholar at the Department of Radiation Oncology of Stanford University.
Dr. Lundberg awarded his Ph.D. in Medical Bioinformatics, focusing on the transcriptional gene expression signatures in breast cancer from Karolinska Institute - Sweden. He mainly worked with data derived from clinically annotated cancer specimens of Swedish and International breast cancer cohorts. During his Ph.D. Dr. Lundberg acquired knowledge about molecular biomarkers for prognostication and prediction of treatment response in breast cancer.
He holds two Master's of Science degrees in Bioinformatics from Lund University - Sweden and Computational Biophysics/Biochemistry from Stockholm University - Sweden, respectively.
Dr. Lundberg is currently working in Prof. Li Lab, involving in the development and clinical validation of prognostic and diagnostic biomarkers for early detection of cancer, as well as prediction of treatment response in precision cancer medicine.